ACRS Aclaris Therapeutics
- 3.800
- -0.520-12.04%
- 4.010
- +0.210+5.53%
Aclaris Therapeutics News
Aclaris Therapeutics | 10-Q: Q3 2024 Earnings Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | 10-Q: Q2 2024 Earnings Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | 10-Q: Q1 2024 Earnings Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | 10-K: FY2023 Annual Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | 10-Q: Q3 2023 Earnings Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | 10-Q: Q2 2023 Earnings Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | 10-Q: Q1 2023 Earnings Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | 10-K: FY2022 Annual Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | 10-Q: Q3 2022 Earnings Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | 10-Q: Q2 2022 Earnings Report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
Analysis
Price Target
No Data
No Data